LSCGX
Price
$22.39
Change
-$0.30 (-1.32%)
Updated
Jan 14 closing price
Net Assets
134.79M
RPEBX
Price
$70.01
Change
-$0.43 (-0.61%)
Updated
Jan 14 closing price
Net Assets
162.72B
Interact to see
Advertisement

LSCGX vs RPEBX

Header iconLSCGX vs RPEBX Comparison
Open Charts LSCGX vs RPEBXBanner chart's image
Loomis Sayles Global Growth C
Price$22.39
Change-$0.30 (-1.32%)
VolumeN/A
Net Assets134.79M
American Funds New Perspective R2E
Price$70.01
Change-$0.43 (-0.61%)
VolumeN/A
Net Assets162.72B
LSCGX vs RPEBX Comparison Chart in %
View a ticker or compare two or three
VS
LSCGX vs. RPEBX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSCGX is a Hold and RPEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 163B vs. LSCGX (135M). RPEBX pays higher dividends than LSCGX: RPEBX (0.57) vs LSCGX (0.00). LSCGX was incepted earlier than RPEBX: LSCGX (10 years) vs RPEBX (11 years). LSCGX (2.13) is less costly to investors than RPEBX (1.21). RPEBX is a more actively managed with annual turnover of: 24.00 vs. LSCGX (6.00). RPEBX has a lower initial minimum investment than LSCGX: RPEBX (250) vs LSCGX (2500). LSCGX annual gain was more profitable for investors over the last year : 20.05 vs. RPEBX (18.20). LSCGX return over 5 years is better than : 25.71 vs. RPEBX (16.40).
LSCGXRPEBXLSCGX / RPEBX
Total Expense Ratio1.951.21161%
Annual Report Gross Expense Ratio2.131.21176%
Fund Existence10 years11 years-
Gain YTD1.8862.83267%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets135M163B0%
Annual Yield % from dividends0.000.57-
Returns for 1 year20.0518.20110%
Returns for 3 years77.8245.46171%
Returns for 5 years25.7116.40157%
Returns for 10 yearsN/A120.89-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWOMX19.45N/A
N/A
Fidelity Women's Leadership
CMRGX10.21N/A
N/A
Calamos Merger Arbitrage I
BRWCX25.88-0.06
-0.23%
MFS Blended Research Growth Eq C
JFNSX77.45-0.23
-0.30%
Janus Henderson Global Life Sciences S
GIEYX16.25-0.11
-0.67%
GuideStone Funds International Eq Instl